
Sara K. Tedeschi
Articles
-
Dec 10, 2024 |
acrjournals.onlinelibrary.wiley.com | Tristan Pascart |Augustin Latourte |Sara K. Tedeschi |Mariano Andrés |Fabio Becce |Thomas Bardin | +5 more
INTRODUCTION Calcium pyrophosphate deposition (CPPD) disease occurs as a consequence of the pathological presence of calcium pyrophosphate (CPP) crystals inside joints.1-4 It is an umbrella term comprising different acute and chronic phenotypes, which often coexist.5, 6 Acute CPP crystal arthritis presents with severe joint pain and swelling, like gout flares, commonly affecting knees, wrists, and ankles and lasting for several days to weeks.7-10 These episodes can be recurrent.
-
Oct 10, 2024 |
acrjournals.onlinelibrary.wiley.com | Sara K. Tedeschi
Corresponding author: Sara Tedeschi, MD, MPH, Brigham and Women's Hospital, 60 Fenwood Road, Boston, MA 02115, E-mail: [email protected]; tel: +1 617 264 5904 This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/art.43024.
-
Aug 21, 2024 |
ard.bmj.com | Sho Fukui |Wolfgang C. Winkelmayer |Sara K. Tedeschi |Javier Marrugo
AbstractIntroduction Chronic kidney disease (CKD) is a common comorbidity of rheumatoid arthritis (RA). The association of longitudinal RA disease activity with long-term kidney function has remained uncertain. Method We analysed a multicentre prospective RA registry in the USA from 2001 to 2022. The exposure was updated time-averaged Clinical Disease Activity Index (TA-CDAI) categories from study enrolment. The primary outcome was a longitudinal estimated glomerular filtration rate (eGFR) change.
-
Aug 1, 2024 |
acrjournals.onlinelibrary.wiley.com | Tristan Pascart |Augustin Latourte |Sara K. Tedeschi
Objective To examine the disease, demographic, and imaging features associated with different inflammatory phenotypes of calcium pyrophosphate deposition (CPPD) disease i.e., recurrent acute CPP crystal arthritis, chronic CPP crystal inflammatory arthritis, and crowned dens syndrome (CDS).
-
May 9, 2024 |
ard.bmj.com | Sara K. Tedeschi |Keigo Hayashi |Yuqing Zhang |Hyon K. Choi
Objective To investigate gout flare rates based on repeated serum urate (SU) measurements in a randomised controlled trial of urate-lowering therapy (ULT), accounting for dropout and death. Methods We performed a secondary analysis using data from Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout, which randomised participants to febuxostat or allopurinol, titrated to target SU <6 mg/dL with flare prophylaxis for 6 months.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →